Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy von Varella, Leticia, Eziokwu, Akaolisa Samuel, Jia, Xuefei, Kruse, Megan, Moore, Halle C. F., Budd, George Thomas, Abraham, Jame, Montero, Alberto J.

Volltext

Real-world Outcomes of Cyclin-dependent Kinase Inhibitors Continued Beyond First Disease Progression in Hormone Receptor-positive Metastatic Breast Cancer von Samuel Eziokwu, Akaolisa, Varella, Leticia, Lynn Kruse, Megan, Jia, Xuefei, Moore, Halle C.F., Thomas Budd, George, Abraham, Jame, Montero, Alberto J.

Volltext

Real-world evidence evaluating continuation of CDK4/6 inhibitors beyond first progression in hormone receptor-positive (HR+) metastatic breast cancer von Eziokwu, Akaolisa Samuel, Varella, Leticia, Kruse, Megan Lynn, Jia, Xuefei, Moore, Halle C. F., Budd, George Thomas, Abraham, Jame, Montero, Alberto J.

Volltext

Real world clinical outcomes of palbociclib in hormone receptor positive (HR+) metastatic breast cancer (MBC) patients von Eziokwu, Akaolisa Samuel, Varella, Leticia, Kruse, Megan Lynn, Jia, Xuefei, Moore, Halle C. F., Budd, George Thomas, Abraham, Jame, Montero, Alberto J.

Volltext

Incidence of severe late toxicities of head and neck squamous cell cancer (HNSCC) treatment in the era of intensity modulated radiotherapy (IMRT) von Eziokwu, Akaolisa Samuel, Koyfman, Shlomo A., Reddy, Chandana A., Matia, Brian, Woody, Neil McIver, Joshi, Nikhil Purushottam, Burkey, Brian B., Scharpf, Joseph, Lamarre, Eric, Prendes, Brandon, Lorenz, Robert, Ku, Jamie, Adelstein, David J., Geiger, Jessica Lyn

Volltext